These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 17254461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A large series of immunohistochemically confirmed cases of congenital muscular dystrophy seen over a period of one decade.
    Nagappa M, Atchayaram N, Narayanappa G.
    Neurol India; 2013; 61(5):481-7. PubMed ID: 24262449
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Congenital muscular dystrophy with laminin-a2 deficiency in early infancy: diagnosis and long-term follow-up].
    Panteliadis C, Karatza E, Xinias I, Flaris N, Tzitiridou M, Ramantani G.
    Klin Padiatr; 2005; 217(5):281-5. PubMed ID: 16167276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Merosin negative congenital muscular dystrophy: a short report.
    Ralte AM, Sharma MC, Gulati S, Das M, Sarkar C.
    Neurol India; 2003 Sep; 51(3):417-9. PubMed ID: 14652462
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, Voit T, Sewry CA, Guicheney P, Muntoni F.
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse.
    Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T.
    Neuromuscul Disord; 1997 Jan; 7(1):7-12. PubMed ID: 9132144
    [Abstract] [Full Text] [Related]

  • 15. Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.
    Voit T, Sewry CA, Meyer K, Hermann R, Straub V, Muntoni F, Kahn T, Unsöld R, Helliwell TR, Appleton R.
    Neuropediatrics; 1995 Jun; 26(3):148-55. PubMed ID: 7477753
    [Abstract] [Full Text] [Related]

  • 16. [Non-Fukuyama type congenital muscular dystrophy--merosin deficient and positive forms].
    Nonaka I.
    Nihon Rinsho; 1997 Dec; 55(12):3176-80. PubMed ID: 9436431
    [Abstract] [Full Text] [Related]

  • 17. Congenital muscular dystrophy with secondary merosin deficiency and normal brain MRI: a novel entity?
    Mercuri E, Sewry CA, Brown SC, Brockington M, Jungbluth H, DeVile C, Counsell S, Manzur A, Muntoni F.
    Neuropediatrics; 2000 Aug; 31(4):186-9. PubMed ID: 11071142
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.